Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
North Carolina Medical Journal
|
September 16, 2003
How well do we treat elevated LDL-cholesterol? Results from a University Residents' Clinic
Peter D Higgins, Cheryl Russo, Mark Scheurer, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
June 12, 2012
The human gut microbiome: current knowledge, challenges, and future directions
Maneesh Dave, Peter D Higgins, Sumit Middha, et al.
Cureus
|
September 10, 2025
"Cut and Cover": A Case Series of Dual Modality Treatment With Stricturetomy and Stenting for Inflammatory Bowel Disease-Related Strictures
Matthew J Miller, Abhishek Satishchandran, Jeffrey Berinstein, et al.
Cureus
|
October 13, 2025
Correction: "Cut and Cover": A Case Series of Dual Modality Treatment With Stricturotomy and Stenting for Inflammatory Bowel Disease-Related Strictures
Matthew J Miller, Abhishek Satishchandran, Jeffrey Berinstein, et al.
Inflammatory Bowel Diseases
|
March 19, 2013
Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts
Laura A Johnson, Eva S Rodansky, Kay L Sauder, et al.
The American Journal of Gastroenterology
|
November 17, 2023
Racial Disparity in Esophageal Squamous Cell Carcinoma Treatment and Survival in the United States
Mohamed Noureldin, Joel H Rubenstein, Esteban Urias, et al.
Clinical and Translational Gastroenterology
|
February 28, 2023
Social Network Diversity and the Daily Burden of Inflammatory Bowel Disease
LaVana Greene-Higgs, Ariel Jordan, Jessica Sheehan, et al.
Journal of Crohn'S & Colitis
|
June 1, 2013
Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III)
Fernando Magro, Laurent Peyrin-Biroulet, Harry Sokol, et al.
Inflammatory Bowel Diseases
|
September 7, 2016
Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers
Hans H Herfarth, Susan Jackson, Barbara G Schliebe, et al.
The American Journal of Gastroenterology
|
October 16, 2013
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging
William A Faubion, Joel G Fletcher, Sharon O'Byrne, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
North Carolina Medical Journal
|
September 16, 2003
How well do we treat elevated LDL-cholesterol? Results from a University Residents' Clinic
Peter D Higgins, Cheryl Russo, Mark Scheurer, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
June 12, 2012
The human gut microbiome: current knowledge, challenges, and future directions
Maneesh Dave, Peter D Higgins, Sumit Middha, et al.
Cureus
|
September 10, 2025
"Cut and Cover": A Case Series of Dual Modality Treatment With Stricturetomy and Stenting for Inflammatory Bowel Disease-Related Strictures
Matthew J Miller, Abhishek Satishchandran, Jeffrey Berinstein, et al.
Cureus
|
October 13, 2025
Correction: "Cut and Cover": A Case Series of Dual Modality Treatment With Stricturotomy and Stenting for Inflammatory Bowel Disease-Related Strictures
Matthew J Miller, Abhishek Satishchandran, Jeffrey Berinstein, et al.
Inflammatory Bowel Diseases
|
March 19, 2013
Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts
Laura A Johnson, Eva S Rodansky, Kay L Sauder, et al.
The American Journal of Gastroenterology
|
November 17, 2023
Racial Disparity in Esophageal Squamous Cell Carcinoma Treatment and Survival in the United States
Mohamed Noureldin, Joel H Rubenstein, Esteban Urias, et al.
Clinical and Translational Gastroenterology
|
February 28, 2023
Social Network Diversity and the Daily Burden of Inflammatory Bowel Disease
LaVana Greene-Higgs, Ariel Jordan, Jessica Sheehan, et al.
Journal of Crohn'S & Colitis
|
June 1, 2013
Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III)
Fernando Magro, Laurent Peyrin-Biroulet, Harry Sokol, et al.
Inflammatory Bowel Diseases
|
September 7, 2016
Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers
Hans H Herfarth, Susan Jackson, Barbara G Schliebe, et al.
The American Journal of Gastroenterology
|
October 16, 2013
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging
William A Faubion, Joel G Fletcher, Sharon O'Byrne, et al.
Page
of 2